Nine-valent cervical cancer vaccine age

You can't get the 9-valent cervical vaccine when you reach a certain age. A 38-year-old woman wanted to get the new 9-valent cervical cancer vaccine, but was told by her friends that the vaccine has no practical effect and is not recommended. In fact, this is not the case. There is no definite age limit for the 9-valent HPV vaccine. So is it necessary for people over the age of 38-54 to get the vaccine?

What is the appropriate age to get the 9-valent cervical vaccine?

People aged 9-45 can get the vaccine. In fact, this is just a category. Preventing HPV virus infection is the purpose of vaccination. So age is not the most important. Sexual behavior is the most important factor in HPV virus infection. Therefore, it is necessary for couples to get the cervical cancer vaccine. Naturally, it is most cost-effective to get the vaccine when you are not having sex.

If you are over the age limit and don't get vaccinated, can wearing a condom prevent HPV infection?

Because HPV is widely present in the external environment, even if a condom is worn during sexual intercourse, it cannot 100% prevent HPV from being transmitted to the cervix. Therefore, the best way is to get vaccinated before the risk occurs.

Is it necessary to do anti-cancer screening for cervical cancer?

Must must must must! The screening is exactly the same for vaccinated and unvaccinated people, and the frequency and method of screening cannot be reduced just because they have been vaccinated.

Women under 21 years old have stronger immune resistance, so screening is not recommended for women at this stage.

For women aged 21 to 29, it is strongly recommended to have a cytology screening (Papanicolaou acid-fast staining or TCT test) every 3 years.

Women aged 30 to 65 should undergo HPV testing and cervical cytology every 5 years, or cytology every 3 years. Women over 65 do not need to be screened again if the results of previous tests have been negative. However, if the patient has previously suffered from CIN II, CIN II or carcinoma in situ, he or she must be re-examined for at least 20 years after treatment.